120
Participants
Start Date
July 18, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
"Pharmacogenomic Testing with the Global Diversity Array with Enhanced PGx"
Pharmacogenomic (PGx) microarray testing will test for certain pharmcogenes that can guide prescribing of certain cancer treatments and/or supportive care medications.
RECRUITING
Atrium Health Levine Cancer, Charlotte
Atrium Health Levine Cancer Institute
OTHER
Wake Forest University Health Sciences
OTHER